CellSource Co (TSE:4880) Tax Provision: 円-110 Mil (TTM As of Jul. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4880 CellSource Co Ltd TSE:4880
69 GF Score
Price 円323.00
GF Value 円1,032.15
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is CellSource Co Tax Provision?

CellSource Co TSE:4880 -2.42% 69 Tax Provision is 円-110 Mil as of Jul. 2026. GuruFocus rates TSE:4880 with a GF Score™ of 69/100 and a GF Value™ of 円1,032.15 (Significantly Undervalued). The stock has 6 warning signs investors should review.

CellSource Co's tax provision for the three months ended in Jul. 2026 was 円-21 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jul. 2026 was 円-110 Mil.

CellSource Co Tax Provision Historical Data

* Premium members only.

The historical data trend for CellSource Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSource Co Tax Provision Chart

CellSource Co Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Tax Provision
Get a 7-Day Free Trial -354.97 -565.80 -316.54 -57.00 -99.19

CellSource Co Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.58 -51.70 -17.28 -19.86 -20.79
TSE:4880
69GF Score
CellSource Co Ltd TSE:4880
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSource Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jul. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-110 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of 円-110 Mil mean?
CellSource Co (TSE:4880) has a Tax Provision of 円-110 Mil as of Jul. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on CellSource Co and its competitors.
Is CellSource Co's Tax Provision too high?
CellSource Co's current Tax Provision is 円-110 Mil. Overall, CellSource Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellSource Co's Tax Provision compare to VRTX and REGN?
CellSource Co's Tax Provision of 円-110 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Biotechnology company?
A good Tax Provision depends on the Biotechnology industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on CellSource Co and its competitors. CellSource Co's current Tax Provision is 円-110 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSource Co stock overvalued right now?
Based on GuruFocus' analysis, CellSource Co (TSE:4880) is currently considered Significantly Undervalued. The stock's GF Value™ is 円1,032.15, compared to a current price of 円323.00 — trading 68.7% below its estimated fair value. The current Tax Provision is 円-110 Mil. CellSource Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For CellSource Co (TSE:4880), the current Tax Provision is 円-110 Mil as of Jul. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellSource Co (TSE:4880) Overvalued in 2026?

Based on GuruFocus' analysis, CellSource Co stock appears to be undervalued. The current stock price of 円323.00 is trading 68.7% below its estimated GF Value™ of 円1,032.15. GuruFocus considers CellSource Co to be Significantly Undervalued.

Key valuation signals for TSE:4880:

  • Tax Provision: 円-110 Mil
  • GF Value™: 円1,032.15 vs. price of 円323.00 (68.7% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the TSE:4880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CellSource Co Business Description

Address Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
69GF Score

Get the complete analysis for TSE:4880

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円323.00
Price
円1,032.15
GF Value